Lars Wallentin, MD

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Abbott(MODEST) RESEARCH/RESEARCH GRANTS: Boehringer-Ingelheim(SIGNIFICANT), GlaxoSmithKline(SIGNIFICANT), AstraZeneca(SIGNIFICANT), Merck/Schering-Plough(SIGNIFICANT), Bristol-Myers Squibb/Pfizer(SIGNIFICANT), Roche Diagnostics(SIGNIFICANT)

View Full Disclosure